RNA Interference for Viral Infections

Stephen Blake, Fawzi F. Bokhari, Nigel A.J. McMillan

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

The treatment of viral infections has relied on pre-emptive vaccination or use of a limited range of anti-viral drugs. However, the majority of viruses have no available drugs and treatment is merely supportive. RNA interference (RNAi) offers the ability to directly and rapidly treat virus infections via the targeting of viral genes. Indeed, clinical trials have already been undertaken with promising results. Here we review the current state of the RNAi field for the treatment of viral infections such as HIV, human papillomavirus and HCV. We also review novel strategies including the concept of targeting self-genes to limit viral infection and activating the immune system for improved outcomes. Finally we examine innovative approaches being pursued at the Australian Infectious Diseases Research Centre including the use of highthroughput siRNA screens to identify new antiviral targets.

LanguageEnglish
Pages1411-1420
Number of pages10
JournalCurrent Drug Targets
Volume13
Issue number11
DOIs
Publication statusPublished - 5 Oct 2012
Externally publishedYes

Keywords

  • HCV
  • HIV
  • HPV
  • RNA interference
  • Screening

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Blake, Stephen ; Bokhari, Fawzi F. ; McMillan, Nigel A.J. / RNA Interference for Viral Infections. In: Current Drug Targets. 2012 ; Vol. 13, No. 11. pp. 1411-1420.
@article{228c7e66c19e4086b66ee95095b331a6,
title = "RNA Interference for Viral Infections",
abstract = "The treatment of viral infections has relied on pre-emptive vaccination or use of a limited range of anti-viral drugs. However, the majority of viruses have no available drugs and treatment is merely supportive. RNA interference (RNAi) offers the ability to directly and rapidly treat virus infections via the targeting of viral genes. Indeed, clinical trials have already been undertaken with promising results. Here we review the current state of the RNAi field for the treatment of viral infections such as HIV, human papillomavirus and HCV. We also review novel strategies including the concept of targeting self-genes to limit viral infection and activating the immune system for improved outcomes. Finally we examine innovative approaches being pursued at the Australian Infectious Diseases Research Centre including the use of highthroughput siRNA screens to identify new antiviral targets.",
keywords = "HCV, HIV, HPV, RNA interference, Screening",
author = "Stephen Blake and Bokhari, {Fawzi F.} and McMillan, {Nigel A.J.}",
year = "2012",
month = "10",
day = "5",
doi = "10.2174/138945012803530161",
language = "English",
volume = "13",
pages = "1411--1420",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "11",

}

Blake, S, Bokhari, FF & McMillan, NAJ 2012, 'RNA Interference for Viral Infections', Current Drug Targets, vol. 13, no. 11, pp. 1411-1420. https://doi.org/10.2174/138945012803530161

RNA Interference for Viral Infections. / Blake, Stephen; Bokhari, Fawzi F.; McMillan, Nigel A.J.

In: Current Drug Targets, Vol. 13, No. 11, 05.10.2012, p. 1411-1420.

Research output: Contribution to journalReview article

TY - JOUR

T1 - RNA Interference for Viral Infections

AU - Blake, Stephen

AU - Bokhari, Fawzi F.

AU - McMillan, Nigel A.J.

PY - 2012/10/5

Y1 - 2012/10/5

N2 - The treatment of viral infections has relied on pre-emptive vaccination or use of a limited range of anti-viral drugs. However, the majority of viruses have no available drugs and treatment is merely supportive. RNA interference (RNAi) offers the ability to directly and rapidly treat virus infections via the targeting of viral genes. Indeed, clinical trials have already been undertaken with promising results. Here we review the current state of the RNAi field for the treatment of viral infections such as HIV, human papillomavirus and HCV. We also review novel strategies including the concept of targeting self-genes to limit viral infection and activating the immune system for improved outcomes. Finally we examine innovative approaches being pursued at the Australian Infectious Diseases Research Centre including the use of highthroughput siRNA screens to identify new antiviral targets.

AB - The treatment of viral infections has relied on pre-emptive vaccination or use of a limited range of anti-viral drugs. However, the majority of viruses have no available drugs and treatment is merely supportive. RNA interference (RNAi) offers the ability to directly and rapidly treat virus infections via the targeting of viral genes. Indeed, clinical trials have already been undertaken with promising results. Here we review the current state of the RNAi field for the treatment of viral infections such as HIV, human papillomavirus and HCV. We also review novel strategies including the concept of targeting self-genes to limit viral infection and activating the immune system for improved outcomes. Finally we examine innovative approaches being pursued at the Australian Infectious Diseases Research Centre including the use of highthroughput siRNA screens to identify new antiviral targets.

KW - HCV

KW - HIV

KW - HPV

KW - RNA interference

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84866950355&partnerID=8YFLogxK

U2 - 10.2174/138945012803530161

DO - 10.2174/138945012803530161

M3 - Review article

VL - 13

SP - 1411

EP - 1420

JO - Current Drug Targets

T2 - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 11

ER -